HEALTH● LOWSep 28 · Sep 28, 2026, 12:19 PM
AbbVie’s Juvmo wins FDA approval for Parkinson’s disease
Seeking Alpha Tech · global
AbbVie's Juvmo has received FDA approval for the treatment of Parkinson's disease. This marks a significant development for patients and the medical community in finding new treatment options.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH1h agoThe health of Leo XIV: the Pope advances in his recovery, but uncertainty remains about his visit to South AmericaClarínHEALTH2h agoHealthcare workers protest in virtually every state over pay, shortages and staffingMexico News DailyHEALTH3h agoKFF: Individual health insurance enrollment fell 18 percent in JuneThe HillHEALTH3h agoPaxton suing Gerber and Nestlé over alleged arsenic and lead in baby foodThe Hill